Charles Lanning
Lebanon, TNNPI 1760405500
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 29.3% of the total. Reporting peaked in 2021 at $789 and has fallen 68.5% since, to $248 in 2022.
Across 105 payments — averaging $18.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$562
- Astellas Pharma US Inc$174
- Daiichi Sankyo Inc.$173
- Mayne Pharma Commercial LLC$111
- Channel Medsystems, Inc.$92
- Merck$85
- plus $723 from 20 others
What the payments were for
- Food & beverage$1,90999%
- Education$131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 32 | $562 |
| Astellas Pharma US Inc | 9 | $174 |
| Daiichi Sankyo Inc. | 9 | $173 |
| Mayne Pharma Commercial LLC | 6 | $111 |
| Channel Medsystems, Inc. | 1 | $92 |
| Merck | 5 | $85 |
| Boston Scientific | 6 | $83 |
| Roche Diagnostics Corporation | 3 | $66 |
| Intuitive Surgical | 1 | $56 |
| Pfizer | 4 | $53 |
| Corcept Therapeutics | 1 | $47 |
| Mylan Pharmaceuticals Inc. | 4 | $47 |
| Coloplast | 3 | $45 |
| Coopersurgical, Inc. | 3 | $43 |
| Hologic Sales And Service, LLC | 2 | $39 |
| Amgen | 2 | $39 |
| Organon | 2 | $31 |
| Evofem Biosciences, Inc. | 2 | $28 |
| Duchesnay USA Incorporated | 2 | $28 |
| Therapeuticsmd, Inc. | 2 | $24 |
| Bayer | 1 | $21 |
| Myovant Sciences Inc. | 1 | $18 |
| Avanos Medical | 1 | $16 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $13 |
| Olympus America Inc. | 1 | $12 |
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.